SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST (1490)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II GBM IGG ANTIBODY EIA TEST medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-glomerular basement membrane (GBM) antibodies (K011348 | K011348) HIGH
Effective Date: 2001-06-22

Other General Immunology Devices:

Medical DeviceComplexity
Beckman Coulter AQUIOS CL Flow Cytometry SystemView Complexity
ALPCO ORGenTec Anti-TG Pin Immuno AssayView Complexity
Beckman Coulter Unicel DxC 600 Synchron Clinical SystemView Complexity
Phadia 100View Complexity
The Binding Site SPAplusView Complexity
Beckman Auto ICSView Complexity
Ortho Epstein-Barr Virus VCA-IgG Antibody ELISAView Complexity
Quest International Inc. SeraQuest EBV EA-D IgG ELISAView Complexity
Roche Diagnostics Cobas MiraView Complexity
TOSOH AIA-600 II W/O INT BCRView Complexity